Evidence map›Paper›PMID 33433889›Full record

ArticlePituitary2021

Transcriptome profiling of insulin sensitive tissues from GH deficient mice following GH treatment.

Jonathan A Young, Mat Buchman, Silvana Duran-Ortiz, Colin Kruse, Stephen Bell, John J Kopchick, Darlene E Berryman, Edward O List

Open access · greenAbstract read
In one paragraph

Article in Pituitary, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jonathan A YoungEdison Biotechnology Institute, Ohio University, Athens, OH, 45701, USA.ORCID http://orcid.org/0000-0003-1770-1391
Mat BuchmanEdison Biotechnology Institute, Ohio University, Athens, OH, 45701, USA.
Silvana Duran-OrtizEdison Biotechnology Institute, Ohio University, Athens, OH, 45701, USA.ORCID http://orcid.org/0000-0001-8870-4077
Colin KruseEdison Biotechnology Institute, Ohio University, Athens, OH, 45701, USA.ORCID http://orcid.org/0000-0001-7070-8889
Stephen BellEdison Biotechnology Institute, Ohio University, Athens, OH, 45701, USA.ORCID http://orcid.org/0000-0001-6950-7270
John J KopchickEdison Biotechnology Institute, Ohio University, Athens, OH, 45701, USA.ORCID http://orcid.org/0000-0003-4561-2177
Darlene E Berryman *Edison Biotechnology Institute, Ohio University, Athens, OH, 45701, USA.ORCID http://orcid.org/0000-0003-4240-9229
Edward O List *Edison Biotechnology Institute, Ohio University, Athens, OH, 45701, USA. list@ohio.edu.ORCID http://orcid.org/0000-0002-8230-6331
Biotechnology Institute · US

Funding

Modulating Growth Hormone Action as a Target for Improved Health and LongevityR01AG059779 · NIA · OHIO UNIVERSITY ATHENS · PI John Joseph Kopchick · 2018 to 2026
$4.7M
Merck KGaA Grant for Growth InnovationNIA NIH HHS #AG059779NIA NIH HHS R01 AG059779
6 · The paper itself

Abstract

purposeMost studies that have examined the transcriptional response to GH have been performed with a single tissue. Thus, the current study performed RNASeq across three insulin-sensitive tissues of GH-treated GH deficient (GHKO) mice.

methodsGHKO mice were injected with recombinant human GH (hGH) or vehicle daily for 5 days and adipose, liver, and muscle tissues were collected 4 h after the final injection. RNA was isolated from the tissues and sequenced. Genes that were differentially expressed between GH and vehicle treatments were further analyzed. Enrichment analysis and topology-aware pathway analysis were performed.

resultsGHKO mice treated with hGH had expected phenotypic alterations, with increased body, fat, fluid, liver, and muscle mass, and increased serum IGF-1 and insulin. 55 Genes were differentially expressed in all three tissues, including the canonical GH targets Igf1, Igfals, and Cish. Enrichment analysis confirmed the canonical GH response in select tissues, such as cell proliferation, metabolism, and fibrosis. The JAK/STAT pathway was the only pathway significantly altered in all three tissues.

conclusionsAs expected, GH caused expression changes of many known target genes, although new candidate GH targets were identified. Liver and muscle appear to be more GH sensitive than adipose tissue due to the larger number of DEG and pathways significantly altered, but adipose still has a characteristic GH response. The diversity of changes uncovered in all three tissues after 5 days of GH treatment highlights the multiplicity of GH's effects in its target tissues.

Indexed as

Growth HormoneInsulinAdipose TissueAnimalsGene Expression ProfilingInsulin-Like Growth Factor ILiverMiceGrowth HormoneInsulinInsulin-Like Growth Factor IAdiposeGrowth hormoneLiverMuscleRNASeqTranscriptome

Identifiers

PMID33433889
PMCPMC8122029
OpenAlexW3118743600

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.